ADC Therapeutics SA
NYSE: ADCTIncorporated in Switzerland · 3 known investors
Find your way into ADC Therapeutics SA
3,405 people in our graph share verified history with the ADC Therapeutics SA team — schools, employers, funds. One of them is your warm intro.
René Kuijtenunlockedknows Ameet Mallik · together at McKinsey & Company (overlapped)
knows the team · via Northwestern University
×8knows the team · via McKinsey & Company
knows the team · via Williams College
knows the team · via UNC Kenan-Flagler Business School
ADC Therapeutics is a biopharmaceutical company that develops antibody drug conjugates and other therapies focused on hematology and oncology. It operates in the biotech and pharmaceutical industry.
Founders & leadership
AM
Ameet MallikinChief Executive OfficerAmeet Mallik is Chief Executive Officer of ADC Therapeutics, a biopharmaceutical company developing antibody drug conjugates for hematologic and oncologic indications. He previously served as CEO of Rafael Holdings, held leadership roles spanning oncology and pharma during 16+ years at Novartis including Executive Vice President of US Oncology, and worked as an Associate Principal at McKinsey & Company; he holds an MBA from Wharton and master's and bachelor's degrees in biotechnology and chemical engineering from Northwestern University.
JC
Jose CarmonaChief Financial Officer
MZ
Mohamed ZakiinChief Medical Officer
KH
Kristen Harrington-SmithinChief Commercial OfficerKristen Harrington-Smith is Chief Commercial Officer at ADC Therapeutics, a biopharmaceutical company developing antibody drug conjugates for hematology and oncology. She has held leadership roles in pharmaceutical product launches and commercialization across multiple therapeutic areas including hematology, oncology, cell and gene therapies, neuroscience, and cardiovascular disease.
DE
David EgeinChief Technical OfficerDavid Ege is Chief Technical Officer at ADC Therapeutics, overseeing manufacturing operations and quality for its antibody drug conjugate therapies. He has over 20 years of pharmaceutical and biotech experience in biologics and vaccines manufacturing, including roles at Merck where he contributed to the development and launch of Gardasil, Gardasil9, and Keytruda, and at Seres Therapeutics where he worked on VOWST's approval.
PG
Peter GrahaminChief Legal OfficerPeter Graham is Chief Legal Officer at ADC Therapeutics, a biopharmaceutical company developing antibody drug conjugates for hematology and oncology. He has held senior legal and compliance roles at publicly and privately held medical device, pharmaceutical, and life sciences companies, with expertise spanning regulatory affairs, corporate governance, M&A, and intellectual property.
KP
Kimberly PopeChief People Officer
Investors · 3
Competitors · 7
by search overlap
Seeking Alpha24 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
TradingView19 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Robinhood17 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
StockTwits16 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Public15 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
Simply Wall St14 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
TipRanks14 shared keywordsFinancial analysis and stock research platform.
Companies competing with ADC Therapeutics SA for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does ADC Therapeutics SA do?
- ADC Therapeutics is a biopharmaceutical company that develops antibody drug conjugates and other therapies focused on hematology and oncology. It operates in the biotech and pharmaceutical industry.
- Who are ADC Therapeutics SA's investors?
- ADC Therapeutics SA's investors include ETCapital, HEALTHCARE ROYALTY PARTNERS, Scientia Ventures.